Payden & Rygel Buys 500 Shares of The Procter & Gamble Company (NYSE:PG)

Payden & Rygel boosted its position in shares of The Procter & Gamble Company (NYSE:PG) by 0.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,780 shares of the company’s stock after acquiring an additional 500 shares during the period. Procter & Gamble accounts for about 1.5% of Payden & Rygel’s holdings, making the stock its 24th biggest position. Payden & Rygel’s holdings in Procter & Gamble were worth $19,187,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Concurrent Investment Advisors LLC increased its position in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after purchasing an additional 4,035 shares during the last quarter. Radnor Capital Management LLC bought a new stake in Procter & Gamble during the 3rd quarter valued at $5,705,000. Welch Group LLC increased its position in shares of Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares during the period. Swiss National Bank raised its stake in shares of Procter & Gamble by 0.6% during the third quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock valued at $1,213,403,000 after acquiring an additional 39,000 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Procter & Gamble by 67.2% during the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on the company. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Evercore ISI upped their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. DA Davidson boosted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Morgan Stanley raised their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Finally, JPMorgan Chase & Co. boosted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Stock Performance

NYSE:PG traded down $0.54 during mid-day trading on Wednesday, hitting $170.22. 1,228,192 shares of the company traded hands, compared to its average volume of 6,648,247. The stock’s fifty day moving average price is $170.07 and its 200-day moving average price is $168.49. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The firm has a market cap of $400.87 billion, a price-to-earnings ratio of 29.35, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the firm posted $1.83 EPS. The firm’s quarterly revenue was down .6% compared to the same quarter last year. Research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Insiders Place Their Bets

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 25.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total value of $6,289,463.60. Following the transaction, the chief executive officer now owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This represents a 12.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 270,727 shares of company stock worth $46,014,037 in the last 90 days. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.